Logo image of UNH

UNITEDHEALTH GROUP INC (UNH) Stock Fundamental Analysis

USA - NYSE:UNH - US91324P1021 - Common Stock

356.67 USD
-4.48 (-1.24%)
Last: 10/16/2025, 6:57:44 PM
354.87 USD
-1.8 (-0.5%)
After Hours: 10/16/2025, 6:57:44 PM
Fundamental Rating

5

Overall UNH gets a fundamental rating of 5 out of 10. We evaluated UNH against 100 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of UNH while its profitability can be described as average. UNH has a correct valuation and a medium growth rate. UNH also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

UNH had positive earnings in the past year.
UNH had a positive operating cash flow in the past year.
In the past 5 years UNH has always been profitable.
In the past 5 years UNH always reported a positive cash flow from operatings.
UNH Yearly Net Income VS EBIT VS OCF VS FCFUNH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

1.2 Ratios

Looking at the Return On Assets, with a value of 6.90%, UNH belongs to the top of the industry, outperforming 86.00% of the companies in the same industry.
UNH has a Return On Equity of 21.20%. This is amongst the best in the industry. UNH outperforms 88.00% of its industry peers.
With a decent Return On Invested Capital value of 7.89%, UNH is doing good in the industry, outperforming 72.00% of the companies in the same industry.
UNH had an Average Return On Invested Capital over the past 3 years of 10.14%. This is in line with the industry average of 9.33%.
Industry RankSector Rank
ROA 6.9%
ROE 21.2%
ROIC 7.89%
ROA(3y)7.06%
ROA(5y)7.43%
ROE(3y)22.21%
ROE(5y)22.85%
ROIC(3y)10.14%
ROIC(5y)10.16%
UNH Yearly ROA, ROE, ROICUNH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

UNH has a better Profit Margin (5.04%) than 77.00% of its industry peers.
UNH's Profit Margin has declined in the last couple of years.
UNH's Operating Margin of 7.27% is fine compared to the rest of the industry. UNH outperforms 71.00% of its industry peers.
In the last couple of years the Operating Margin of UNH has remained more or less at the same level.
Industry RankSector Rank
OM 7.27%
PM (TTM) 5.04%
GM N/A
OM growth 3Y-1.09%
OM growth 5Y-0.16%
PM growth 3Y-15.71%
PM growth 5Y-8.84%
GM growth 3YN/A
GM growth 5YN/A
UNH Yearly Profit, Operating, Gross MarginsUNH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8

3

2. Health

2.1 Basic Checks

UNH has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
UNH has less shares outstanding than it did 1 year ago.
The number of shares outstanding for UNH has been reduced compared to 5 years ago.
Compared to 1 year ago, UNH has a worse debt to assets ratio.
UNH Yearly Shares OutstandingUNH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
UNH Yearly Total Debt VS Total AssetsUNH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B 250B

2.2 Solvency

UNH has a debt to FCF ratio of 3.13. This is a good value and a sign of high solvency as UNH would need 3.13 years to pay back of all of its debts.
UNH's Debt to FCF ratio of 3.13 is fine compared to the rest of the industry. UNH outperforms 77.00% of its industry peers.
A Debt/Equity ratio of 0.73 indicates that UNH is somewhat dependend on debt financing.
UNH has a Debt to Equity ratio (0.73) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 3.13
Altman-Z N/A
ROIC/WACC0.93
WACC8.46%
UNH Yearly LT Debt VS Equity VS FCFUNH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.3 Liquidity

UNH has a Current Ratio of 0.88. This is a bad value and indicates that UNH is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.88, UNH is not doing good in the industry: 81.00% of the companies in the same industry are doing better.
UNH has a Quick Ratio of 0.88. This is a bad value and indicates that UNH is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.88, UNH is doing worse than 72.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.88
UNH Yearly Current Assets VS Current LiabilitesUNH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

4

3. Growth

3.1 Past

UNH shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.40%.
UNH shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 13.07% yearly.
The Revenue has grown by 9.70% in the past year. This is quite good.
The Revenue has been growing by 10.57% on average over the past years. This is quite good.
EPS 1Y (TTM)-5.4%
EPS 3Y13.67%
EPS 5Y13.07%
EPS Q2Q%-40%
Revenue 1Y (TTM)9.7%
Revenue growth 3Y11.65%
Revenue growth 5Y10.57%
Sales Q2Q%12.66%

3.2 Future

The Earnings Per Share is expected to grow by 2.92% on average over the next years.
UNH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.32% yearly.
EPS Next Y-41.32%
EPS Next 2Y-20.06%
EPS Next 3Y-9.21%
EPS Next 5Y2.92%
Revenue Next Year11.7%
Revenue Next 2Y7.76%
Revenue Next 3Y6.88%
Revenue Next 5Y6.32%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
UNH Yearly Revenue VS EstimatesUNH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200B 400B 600B
UNH Yearly EPS VS EstimatesUNH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10 20 30 40 50

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 14.13, the valuation of UNH can be described as correct.
Based on the Price/Earnings ratio, UNH is valued cheaper than 81.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.31. UNH is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 19.99, the valuation of UNH can be described as rather expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as UNH.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.85, UNH is valued at the same level.
Industry RankSector Rank
PE 14.13
Fwd PE 19.99
UNH Price Earnings VS Forward Price EarningsUNH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

UNH's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. UNH is cheaper than 67.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, UNH is valued cheaper than 82.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.77
EV/EBITDA 10.7
UNH Per share dataUNH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300 400

4.3 Compensation for Growth

The decent profitability rating of UNH may justify a higher PE ratio.
A cheap valuation may be justified as UNH's earnings are expected to decrease with -9.21% in the coming years.
PEG (NY)N/A
PEG (5Y)1.08
EPS Next 2Y-20.06%
EPS Next 3Y-9.21%

7

5. Dividend

5.1 Amount

UNH has a Yearly Dividend Yield of 2.40%. Purely for dividend investing, there may be better candidates out there.
UNH's Dividend Yield is rather good when compared to the industry average which is at 2.44. UNH pays more dividend than 94.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, UNH has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.4%

5.2 History

The dividend of UNH is nicely growing with an annual growth rate of 14.73%!
UNH has paid a dividend for at least 10 years, which is a reliable track record.
UNH has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)14.73%
Div Incr Years15
Div Non Decr Years34
UNH Yearly Dividends per shareUNH Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

5.3 Sustainability

UNH pays out 36.54% of its income as dividend. This is a sustainable payout ratio.
UNH's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP36.54%
EPS Next 2Y-20.06%
EPS Next 3Y-9.21%
UNH Yearly Income VS Free CF VS DividendUNH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B
UNH Dividend Payout.UNH Dividend Payout, showing the Payout Ratio.UNH Dividend Payout.PayoutRetained Earnings

UNITEDHEALTH GROUP INC

NYSE:UNH (10/16/2025, 6:57:44 PM)

After market: 354.87 -1.8 (-0.5%)

356.67

-4.48 (-1.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)10-28 2025-10-28/amc
Inst Owners86.49%
Inst Owner Change0.06%
Ins Owners0.17%
Ins Owner Change2.84%
Market Cap323.03B
Analysts75.63
Price Target348.76 (-2.22%)
Short Float %1.59%
Short Ratio0.82
Dividend
Industry RankSector Rank
Dividend Yield 2.4%
Yearly Dividend8.19
Dividend Growth(5Y)14.73%
DP36.54%
Div Incr Years15
Div Non Decr Years34
Ex-Date09-15 2025-09-15 (2.21)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.05%
Min EPS beat(2)-9.92%
Max EPS beat(2)-2.18%
EPS beat(4)2
Avg EPS beat(4)-2.67%
Min EPS beat(4)-9.92%
Max EPS beat(4)1.12%
EPS beat(8)6
Avg EPS beat(8)0.29%
EPS beat(12)10
Avg EPS beat(12)1.09%
EPS beat(16)14
Avg EPS beat(16)1.55%
Revenue beat(2)0
Avg Revenue beat(2)-1.85%
Min Revenue beat(2)-2.79%
Max Revenue beat(2)-0.91%
Revenue beat(4)1
Avg Revenue beat(4)-1.27%
Min Revenue beat(4)-2.79%
Max Revenue beat(4)0.55%
Revenue beat(8)3
Avg Revenue beat(8)-0.56%
Revenue beat(12)5
Avg Revenue beat(12)-0.28%
Revenue beat(16)8
Avg Revenue beat(16)-0.12%
PT rev (1m)4.55%
PT rev (3m)-10.24%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-43.82%
EPS NY rev (1m)0.11%
EPS NY rev (3m)-26.59%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)-0.3%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)-0.35%
Valuation
Industry RankSector Rank
PE 14.13
Fwd PE 19.99
P/S 0.76
P/FCF 12.77
P/OCF 11.15
P/B 3.22
P/tB 3.22
EV/EBITDA 10.7
EPS(TTM)25.24
EY7.08%
EPS(NY)17.84
Fwd EY5%
FCF(TTM)27.93
FCFY7.83%
OCF(TTM)32
OCFY8.97%
SpS466.86
BVpS110.93
TBVpS110.93
PEG (NY)N/A
PEG (5Y)1.08
Profitability
Industry RankSector Rank
ROA 6.9%
ROE 21.2%
ROCE 10.15%
ROIC 7.89%
ROICexc 8.82%
ROICexgc 33.7%
OM 7.27%
PM (TTM) 5.04%
GM N/A
FCFM 5.98%
ROA(3y)7.06%
ROA(5y)7.43%
ROE(3y)22.21%
ROE(5y)22.85%
ROIC(3y)10.14%
ROIC(5y)10.16%
ROICexc(3y)11.32%
ROICexc(5y)11.36%
ROICexgc(3y)32.46%
ROICexgc(5y)32.01%
ROCE(3y)13.1%
ROCE(5y)13.1%
ROICexcg growth 3Y-2.11%
ROICexcg growth 5Y-0.12%
ROICexc growth 3Y-2.38%
ROICexc growth 5Y-0.43%
OM growth 3Y-1.09%
OM growth 5Y-0.16%
PM growth 3Y-15.71%
PM growth 5Y-8.84%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover1.37
Health
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 3.13
Debt/EBITDA 2.1
Cap/Depr 87.23%
Cap/Sales 0.87%
Interest Coverage 250
Cash Conversion 82.85%
Profit Quality 118.76%
Current Ratio 0.88
Quick Ratio 0.88
Altman-Z N/A
F-Score8
WACC8.46%
ROIC/WACC0.93
Cap/Depr(3y)84.34%
Cap/Depr(5y)80.61%
Cap/Sales(3y)0.88%
Cap/Sales(5y)0.86%
Profit Quality(3y)124.43%
Profit Quality(5y)123.8%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.4%
EPS 3Y13.67%
EPS 5Y13.07%
EPS Q2Q%-40%
EPS Next Y-41.32%
EPS Next 2Y-20.06%
EPS Next 3Y-9.21%
EPS Next 5Y2.92%
Revenue 1Y (TTM)9.7%
Revenue growth 3Y11.65%
Revenue growth 5Y10.57%
Sales Q2Q%12.66%
Revenue Next Year11.7%
Revenue Next 2Y7.76%
Revenue Next 3Y6.88%
Revenue Next 5Y6.32%
EBIT growth 1Y-3.97%
EBIT growth 3Y10.44%
EBIT growth 5Y10.4%
EBIT Next Year-25.01%
EBIT Next 3Y-3.56%
EBIT Next 5Y4.32%
FCF growth 1Y-33.78%
FCF growth 3Y0.99%
FCF growth 5Y4.56%
OCF growth 1Y-29.96%
OCF growth 3Y2.39%
OCF growth 5Y5.37%